SES Solar

SESI

Drug Manufacturers - Specialty & Generic · Healthcare

Price

$0.00

+0.00 (+0.00%)

Market Cap

$7,308

Winston Score

Winston is serious

Mixed quality — meaningful strengths and weaknesses.

Share count rising — dilution

+141.2% over 13y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 30.3M (2006) → 73.1M (2019)

The data provided contains significant inconsistencies — a company named "SES Solar Inc." placed in the Drug Manufacturers industry within Healthcare, with a market cap of essentially zero and a deeply negative ROIC of nearly -1,420%. These details suggest this may be a shell company, a ticker in transition, or a data error rather than an operating business.

Because reliable, verifiable information about SES Solar Inc. (SESI) as a functioning company is not available, writing a factual two-paragraph description is not possible without risking spreading inaccurate information to investors.

**What you can do:** - Double-check the ticker symbol on a primary source like SEC EDGAR (edgar.sec.gov) - Verify whether this company has filed recent 10-K or 10-Q reports - Confirm the correct industry classification with your data provider

If you can provide corrected or additional details — such as what the company actually does, its products, or a recent filing — I'm happy to write an accurate description right away.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

>+1,000% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

>+1,000% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

↓ Declining (-100% vs prior year)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

69.5%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$150,707 cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

SES Solar grew revenue 10678% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

22.7%

Thin — 22.7% gross margin

Operating Margin

14.3%

Healthy — 14.3% operating margin

ROCE

4.7%

Weak — 4.7% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+324.6%

Fast-growing sales (324.6% YoY)

EPS YoY

N/A

Data not available

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

143%

Turns 143% of profit into real cash

FCF Margin

-0.1%

Burning cash (-0.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

3.07

Heavy debt load (3.07)

Interest Cover

3.01x

Tight — interest eats into profit (3.0x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

0.0x

Attractive valuation — P/E 0.0

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial